Genetic and molecular analysis of brain lesions

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on the genetic and molecular characterization of brain tumors and lesions to improve diagnostic and prognostic classifications. It aims to refine the understanding of the biological mechanisms involved in these conditions and develop new targeted treatment strategies. The study involves the collection of biological samples from patients who have undergone surgery for brain lesions, including tumors and non-tumoral lesions. By utilizing advanced genomic techniques, the research seeks to enhance the classification of these pathologies and identify potential theranostic targets.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Any patient operated on for a brain lesion (e.g. tumors: glioma, LCPSNC, meningioma, or rare tumor) and/or followed up for one of these pathologies.
* Age ≥ 18 years
* Consent or non-opposition of the patient or his/her legal representative (guardian) to participate in the study.

Exclusion Criteria: NA

Where it's running

• Service de Neurochirurgie - Hôpital de la Pitié Salpêtrière
  Paris, France Recruiting
• Service de Neurologie 2 -Hôpital de la Pitié Salpêtrière
  Paris, France Recruiting
• Service de Radiothérapie - Hôpital de la Pittié Salpêtrière
  Paris, France Recruiting

Study contacts

• Study coordinator: Marc Sanson, Prof
• Email: marc.sanson@aphp.fr
• Phone: 01 42 16 03 91

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions

  A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.

  Recruiting Brigham and Women's Hospital · Boston, Massachusetts · NCT07883720

• Maintenance radiotherapy after standard glioblastoma treatment

  This study tests whether a single 2 Gy maintenance radiotherapy dose after standard treatment is safe and feasible for adults with newly diagnosed glioblastoma.

  Recruiting University of Minnesota · Minneapolis, Minnesota · NCT07831772

• BCB-276 CAR T therapy for DIPG in children and young adults

  This study tests BCB-276, a patient's own CAR T cells against DIPG, after standard radiation, to see if it is safe and can help extend survival.

  Recruiting at 3 sites Phase 2 BrainChild Bio, Inc · Los Angeles, California and 5 other locations · NCT07680439

• Temozolomide safety and effectiveness in adults with Grade III–IV glioma

  This study tests how safe and effective Amitzo temozolomide is in adults with Grade III or IV glioma in Iran, without a control group.

  Recruiting NanoAlvand · Tehran · NCT07675070

• Home-based vision training guided by brain imaging

  This study tests whether at‑home, image-guided visual training can improve visual field function for adults with stroke-related vision loss.

  Recruiting Georgetown University · Washington D.C., District of Columbia · NCT07635329

• Memantine and raloxifene to protect memory after brain radiation

  This study tests whether adding memantine and raloxifene to brain radiation can help adults preserve memory better than radiation alone.

  Recruiting Phase 2 The University of Texas Health Science Center at San Antonio · San Antonio, Texas · NCT07470606

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.